Omarigliptin

DB11992InvestigationalSmall molecule

Omarigliptin has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.

Chemical structure of Omarigliptin
Mechanism
Curator reviewed
Formula / weight
C17H20F2N4O3S · 398.43 g/mol (avg)
Code names
MK-3102

Resolves to

Compound
UNIICVP59Q4JE1CAS1226781-44-7ChEMBLCHEMBL2105762ChEBI134735PubChem46209133
Structure
InChIKeyMKMPWKUAHLTIBJ-ISTRZQFTSA-NSMILESCS(=O)(=O)N1C=C2CN(CC2=N1)[C@H]1CO[C@@H]([C@@H](N)C1)C1=CC(F)=CC=C1F
Targets
P27487DPP4

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
656Drug interactionsStructured to mechanism, not free text
Sign in
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Omarigliptin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In